ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
Global Industrial Chain
ag真人平台官方:Global Heparin Injections Business
Product Profile
CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
Company News
ag真人平台官方:Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:Prospectus
ag真人平台官方:Announcements
2025.02.26
VOLUNTARY ANNOUNCEMENT “ENOPARIN” OBTAINS APPROVAL FROM ARGENTINA
2025.02.18
VOLUNTARY ANNOUNCEMENT H1710 INJECTION RECEIVED THE NOTICE OF APPROVAL FOR CLINI...
2025.02.14
VOLUNTARY ANNOUNCEMENT OBTAINING THE GMP CERTIFICATE FROM EMA
2025.01.24
POSITIVE PROFIT ALERT ANNOUNCEMENT FOR THE ESTIMATED 2024 ANNUAL RESULTS
2025.01.02
VOLUNTARY ANNOUNCEMENT ENTERING INTO DISTRIBUTION AGREEMENT WITH YONGTAI PHARMAC...
2024.10.30
2024 THIRD QUARTERLY REPORT
2024.10.17
DATE OF BOARD MEETING
2024.09.26
INTERIM REPORT 2024
2024.08.30
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
2024.08.15
DATE OF BOARD MEETING
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
Scientific Advisory Board
Our Businesses
ag真人平台官方:Heparin Business
ag真人平台官方:CDMO Services
Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Official WeChat Account
ag真人平台官方:Legal Statement
·
ag真人平台官方:Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.